The Goteborg MCI study: Mild cognitive impairment is a heterogeneous condition

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 11, 2005, Pages 1485-1490

  Nordlund, Arto ^a,b   Rolstad, S ^b   Hellstrom P ^b   Sjogren M ^a   Hansen, S ^c   Wallin, A ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMNESIA; ANAMNESIS; ARTICLE; ATTENTION; BRAIN FUNCTION; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DEPTH PERCEPTION; DISEASE SEVERITY; EDUCATION; HUMAN; INTELLIGENCE; LANGUAGE; LANGUAGE TEST; LEARNING; MAJOR CLINICAL STUDY; MEMORY; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 27444435843     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.050385     Document Type: Article

References (58)

1. Kral VA. Senescent forgetfulness: benign and malignant. Can Med Assoc J 1902;86:257-60.
2. Smith G, Ivnik RJ, Petersen RC, et al. Age-associated memory impairment diagnoses: problems of reliability and concerns for terminology. Psychol Aging 1991;6:551-8.
3. Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 1994;6:63-8.
4. Celsis P. Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease? Ann Med 2000;32:6-14.
5. Crook T, Bahar H, Sudilovsky A. Age-associated memory impairment: diagnostic criteria and treatment strategies. Int J Neurol 1987;21-22:73-82.
6. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-8.
7. Palmer K, Fratiglioni L, Winblad B. What is mild cognitive impairment? Variations in definitions and evolution of nondemented persons with cognitive impairment. Acta Neurol Scand Suppl 2003;179:14-20.
8. Bozoki A, Giordani B, Heidebrink JL, et al. Mild cognitive Impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol 2001;58:411-16.
9. Collie A, Maruff P. The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci Biobehav Rev 2000;24:365-74.
10. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397-405.
11. Guarch J, Marcos T, Salamero M, et al. Neuropsychological markers of dementia in patients with memory complaints. Int J Geriatr Psychiatry 2004;19:352-8.
12. Petersen RC, Smith GE, Waring SC, et al. Aging, memory, and mild cognitive impairment. Int Psychogeriatr 1997;9(suppl 1):65-9.
13. Tierney MC, Szalai JP, Snow WG, et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 1996;46:661-5.
14. Bowen J, Teri L, Kukull W, et al. Progression to dementia in patients with isolated memory loss. Lancet 1997;349:763-5.
15. Chen P, Ratcliff G, Belle SH, et al. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2000;55:1847-53.
16. Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001;56:37-42.
17. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-92.
18. Davis HS, Rockwood K. Conceptualization of mild cognitive impairment: a review. Int J Geriatr Psychiatry 2004;19:313-19.
19. Kivipelto M, Helkala EL, Hanninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001;56:1683-9
20. Meyer JS, Xu G, Thornby J, et al. Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease? Stroke 2002;33:1 981-5.
21. Frisoni GB, Galluzzi S, Bresciani L, et al. Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome. J Neurol 2002;249:1423-32.
22. Wallin A, Edman A, Blennow K, et al. Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia. J Geriatr Psychiatry Neurol 1996;9:185-99.
23. Royall DR, Mahurin RK, Gray KF. Bedside assessment of executive cognitive impairment: the executive interview. J Am Geriatr Soc 1992;40:1221-6.
24. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
25. Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr. 1997;9:173- 6; discussion 177-8. (suppl 1).
26. Abstracts of the 31st Annual International Neuropsychological Society Conference. February 5-8, 2003, Honolulu, Hawaii. J Int Neuropsychol Soc 2003;9:135-345.
27. Assessment: neuropsychological testing of adults. Considerations for neurologists. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1996;47:592-9.
28. Wechsler D. WAIS-R manual. New York The Psychological Corporation 1981.
29. Reitan RMW, D. The Halstead-Reitan neuropsychological test battery. Tucson, AZ: Neuropsychology Press, 1985.
30. Geffen GM, Butterworth P, Geffen LB. Test-retest reliability of a new form of the auditory verbal learning test (AVLT) Arch Clin Neuropsychol 1994;9:303-16.
31. Wechsler D. Wechsler memory scale-revised manual. San Antonio, Texas: The Psychological Corporation, 1987.
32. Meyers JM, KR. Rey complex figure test and recognition trial. Odessa, Fl: Psychological Assessment Resources Inc, 1995.
33. Wilson RS, Kaszniak AW, Bacon LD. et al. Facial recognition memory in dementia. Cortex 1982;18:329-36.
34. Binetti G, Cappa SF, Magni E, et al. Disorders of visual and spatial perception in the early stage of Alzheimer's disease. Ann NY Acad Sci 1996;777:221-5.
35. Bandera R, Capitani E, Della Sala S, et al. Discrimination between senile dementia Alzheimer type patients and education matched normal controls by means of a 6-test set Ital J Neurol Sci 1985;6:339-44.
36. Crosson B. Assessment of subtle language deficits in neuropsychological batteries. In: Sburdone RL, eds. Ecological validity of neuropsychological testing. Delray, FL: GR Press/St Lucie Press Inc, 1996.
37. Lezak M. Neuropsychological assessment. New York: Oxford University Press, 1995.
38. Kaplan EG, Weintraub S. The Boston naming test, 2nd ed. Philadelphia: Lea and Febiger, 1983
39. Lukatela K, Malloy P, Jenkins M, et al. The naming deficit in early Alzheimer's and vascular dementia. Neuropsychology 1998;12:565-72.
40. Crossley M, D'Arcy C, Rawson NS. Letter and category fluency in community-dwelling Canadian seniors: a comparison of normal participants to those with dementia of the Alzheimer or vascular type. J Clin Exp Neuropsychol 1997;19:52-62.
41. Della Sala S, Baddeley A, Papagno C, et al. Dual-task paradigm: a means to examine the central executive. Ann NY Acad Sci 1995;769:161-71.
42. Paolo AM, Axelrod BN, Troster AI, et al. Utility of a Wisconsin card sorting test short form in persons with Alzheimer's and Parkinson's disease. J Clin Exp Neuropsychol 1996;18:892-7.
43. Spreen O, Strauss E. A compendium of neuropsychological tests. New York: Oxford University Press, 1998.
44. Holm S. A sequentially rejective multiple test procedure. Scand J Statist 1979;6:65-70.
45. Umetrics. User's guide to Simca-P. Umea, Sweden: Umetrics AB, 2002.
46. Raven J. Guide to using the coloured progressive matrices. London: HK Lewis, 1965.
47. Reisberg B, Ferris SH, de Leon MJ, et al. Global deterioration scale (GDS). Psychopharmacol Bull 1988;24:661-3.
48. Wolf H, Grunwald M, Ecke GM, et al. The prognosis of mild cognitive impairment in the elderly. J Neurol Transm Suppl 1998;54:31-50.
49. Lautenschlager NT, Riemenschneider M, Drzezga A, et al. Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings. Dement Geriatr Cogn Disord 2001;12:379-86.
50. Storandt M, Grant EA, Miller JP, et al. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology 2002;59:1034-41 edited.
51. Grundman M, Petersen RC, Ferris SH, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 2004;61(1):59-66.
52. Graham NL, Emery T, Hodges JR. Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry 2004;75(1):61-71.
53. Visser PJ, Verhey FR, Ponds RW, et al. Diagnosis of preclinical Alzheimer's disease in a clinical setting. Int Psychogeriatr 2001;13(4):411-23.
54. Rasquin SM, Lodder J, Visser PJ, et al. Predictive Accuracy of MCI Subtypes for Alzheimer's Disease and Vascular Dementia in Subjects with Mild Cognitive Impairment: A 2-Year Follow-Up Study. Dement Geriatr Cogn Disord 2004;19(2-3):113-119.
55. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002;8(3):448-60.
56. Rentz DM, Huh TJ, Faust RR, et al. Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals. Neuropsychology 2004;18(1):38-49.
57. Maylor EA, Smith G, Della Sala S, et al. Prospective and retrospective memory in normal aging and dementia: an experimental study. Mem Cognit 2002;30(6):871-84.
58. Luis CA, Loewenstein DA, Acevedo A, et al. Mild cognitive impairment: directions for future research. Neurology 2003;61(4):438-44.